MUC16 Mutations and Prognosis in Gastric Cancer A Little Goes a Long Way

被引：5

作者：

Smyth, Elizabeth C. ^{[1
,2
]}

Fitzgerald, Rebecca C. ^{[3
]}

机构：

[1] Royal Marsden Hosp, Dept Gastrointestinal Oncol & Lymphoma, London, England

[2] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge Biomedical Campus,Hills Rd, Cambridge CB2 OQQ, England

[3] Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Cambridge, England

来源：

JAMA ONCOLOGY | 2018年 / 4卷 / 12期

关键词：

D O I：

10.1001/jamaoncol.2018.2803

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1698 / 1699

页数：3

共 7 条

[1] Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer [J].

Balachandran, Vinod P. ;

Luksza, Marta ;

Zhao, Julia N. ;

Makarov, Vladimir ;

Moral, John Alec ;

Remark, Romain ;

Herbst, Brian ;

Askan, Gokce ;

Bhanot, Umesh ;

Senbabaoglu, Yasin ;

Wells, Daniel K. ;

Cary, Charles Ian Ormsby ;

Grbovic-Huezo, Olivera ;

Attiyeh, Marc ;

Medina, Benjamin ;

Zhang, Jennifer ;

Loo, Jennifer ;

Saglimbeni, Joseph ;

Abu-Akeel, Mohsen ;

Zappasodi, Roberta ;

Riaz, Nadeem ;

Smoragiewicz, Martin ;

Kelley, Z. Larkin ;

Basturk, Olca ;

Goenen, Mithat ;

Levine, Arnold J. ;

Allen, Peter J. ;

Fearon, Douglas T. ;

Merad, Miriam ;

Gnjatic, Sacha ;

Iacobuzio-Donahue, Christine A. ;

Wolchok, Jedd D. ;

DeMatteo, Ronald P. ;

Chan, Timothy A. ;

Greenbaum, Benjamin D. ;

Merghoub, Taha ;

Leach, Steven D. .

NATURE, 2017, 551 (7681) :512-+

[2] Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial [J].

Fuchs, Charles S. ;

Doi, Toshihiko ;

Jang, Raymond W. ;

Muro, Kei ;

Satoh, Taroh ;

Machado, Manuela ;

Sun, Weijing ;

Jalal, Shadia I. ;

Shah, Manish A. ;

Metges, Jean-Phillipe ;

Garrido, Marcelo ;

Golan, Talia ;

Mandala, Mario ;

Wainberg, Zev A. ;

Catenacci, Daniel V. ;

Ohtsu, Atsushi ;

Shitara, Kohei ;

Geva, Ravit ;

Bleeker, Jonathan ;

Ko, Andrew H. ;

Ku, Geoffrey ;

Philip, Philip ;

Enzinger, Peter C. ;

Bang, Yung-Jue ;

Levitan, Diane ;

Wang, Jiangdian ;

Rosales, Minori ;

Dalal, Rita P. ;

Yoon, Harry H. .

JAMA ONCOLOGY, 2018, 4 (05)

[3] MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells [J].

Gubbels, Jennifer A. A. ;

Felder, Mildred ;

Horibata, Sachi ;

Belisle, Jennifer A. ;

Kapur, Arvinder ;

Holden, Helen ;

Petrie, Sarah ;

Migneault, Martine ;

Rancourt, Claudine ;

Connor, Joseph P. ;

Patankar, Manish S. .

MOLECULAR CANCER, 2010, 9

[4] Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer [J].

Hellmann, Matthew D. ;

Callahan, Margaret K. ;

Awad, Mark M. ;

Calvo, Emiliano ;

Ascierto, Paolo A. ;

Atmaca, Akin ;

Rizvi, Naiyer A. ;

Hirsch, Fred R. ;

Selvaggi, Giovanni ;

Szustakowski, Joseph D. ;

Sasson, Ariella ;

Golhar, Ryan ;

Vitazka, Patrik ;

Chang, Han ;

Geese, William J. ;

Antonia, Scott J. .

CANCER CELL, 2018, 33 (05) :853-+

[5] Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer [J].

Li, Xiangchun ;

Pasche, Boris ;

Zhang, Wei ;

Chen, Kexin .

JAMA ONCOLOGY, 2018, 4 (12) :1691-1698

[6]

Muniyan Sakthivel, 2016, Genes Cancer, V7, P110, DOI 10.18632/genesandcancer.104

[7] Tumor Mutational Burden and Response Rate to PD-1 Inhibition [J].

Yarchoan, Mark ;

Hopkins, Alexander ;

Jaffee, Elizabeth M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25) :2500-2501

← 1 →